Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants

Brazil currently has a 10-valent pneumococcal conjugate vaccine (PCV10) pediatric national immunization program (NIP). However, in recent years, there has been significant progressive increases in pneumococcal disease attributed to serotypes 3, 6A, and 19A, which are covered by the 13-valent PCV (PC...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Johnna Perdrizet (Автор), Carlos Felipe S. Santana (Автор), Thais Senna (Автор), Rodrigo Fernandes Alexandre (Автор), Rodrigo Sini de Almeida (Автор), Julia Spinardi (Автор), Matt Wasserman (Автор)
Формат:
Опубликовано: Taylor & Francis Group, 2021-04-01T00:00:00Z.
Предметы:
Online-ссылка:Connect to this object online.
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Internet

Connect to this object online.

3rd Floor Main Library

Подробно о фондах из 3rd Floor Main Library
Шифр: A1234.567
Копировать 1 Доступно